VISIONS is our dedicated customer magazine on innovative technologies and applications in medical imaging. Read about diagnostic imaging in the fields of CT, MRI, X-Ray, Ultrasound, HII and stay up-to-date with the latest developments in your clinical environment.
VISIONS is not only available digitally, it is also a printed magazine. Please let us know – during your online subscription – whether you would like to receive a hardcopy of VISIONS at home or at work. VISIONS magazine appears twice a year and subscription is free.
Do you have any questions, problems with access or do you want to share your own clinical experiences by writing an article? Contact VISIONS!
New name, same great people, service and technology. Worldwide name change celebration.
Infinix-i 4D CT in advanced interventional radiology techniques for treatment of primary liver cancer.
Dedicated to MRI; find articles on many recent achievements, upcoming events and product developments.
Highlights the personal insights of key opinion leaders, reflections on our knowledge and expertise in X-ray.
Launching Toshiba Medical’s SportsMed program which centres on delivering exceptional care to everyone.
Outlines Toshiba Medical’s journey in Area Detector CT and shows our continuing spirit to explore the unknown.
Together, we complete the image; achieve better patient outcomes and, as such, contribute to life and living.
Insights from our President and CEO, Toshio Takiguchi, on why everything we do is Made For Life.
Combining advance diagnostic imaging with minimal invasive intervention to revolutionise tumor treatment.
Revealing the secrets of the past and providing next generation healthcare. Plus “Baby Andrew” a patient story.
Pushing the limits of radiation and contrast dose. Along with finding solutions for key clinical issues with x-ray.
Superiority of lung subtraction above dual energy. Spot fluro – reducing dose in interventional procedures.
Xario enters a new level in ultrasound diagnostics and tumour plus 1cm equals better breast cancer recovery.